HOME ȸ»ç¼Ò°³ ½ÃÀÛÆäÀÌÁö·Î Áñ°Üã±âÃß°¡ ±âÀÚȸ¿ø½Åû
[¸ð¹ÙÀϸðµå] ·Î±×ÀΠȸ¿ø°¡ÀÔ
2024³â04¿ù19ÀÏfri
±â»çÃÖÁ¾ÆíÁýÀÏ: 2024-04-19 14:37:10
´º½ºÈ¨ > µ¿Á¤
2021³â07¿ù16ÀÏ 09½Ã25ºÐ
±ÛÀÚÅ©±â ±â»ç³»¿ë À̸ÞÀϺ¸³»±â ´º½ºÇÁ¸°Æ®Çϱ⠴º½º½ºÅ©·¦Çϱâ
ÇѾç´ë±¸¸®º´¿ø ¼­Çö¹Î ±³¼ö, ¹Ì±¹ÇǺΰúÇÐȸÁö ¿¬±¸ ³í¹® °ÔÀç

[º¸°ÇŸÀÓÁî] ÇѾç´ëÇб³±¸¸®º´¿ø ÇǺΰú ¼­Çö¹Î ±³¼ö(»çÁø)ÆÀ(ÇѾç´ëÇб³±¸¸®º´¿ø ÇǺΰú Àü°øÀÇ ¹Ú¼¼±¤, ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ ÇǺΰúÇб³½Ç ±èÁ¤¼ö ±³¼ö)ÀÌ °Ç°­º¸Çè°ø´Ü Ç¥º»ÄÚȣƮ¿Í Çѱ¹È¯°æ°ø´Ü, ±×¸®°í °¢ ÁöÀÚü ȯ°æ°úÀÇ µ¥ÀÌÅͺ£À̽º¸¦ ÀÌ¿ëÇØ ºÐ¼®ÇÑ ¿¬±¸°¡ ÇǺΰúÇÐ ¿µ¿ª¿¡¼­ °¡Àå ±ÇÀ§ ÀÖ´Â ±¹Á¦ÇмúÁöÀÎ ¹Ì±¹ÇǺΰúÇÐȸÁö(Journal of the American Academy of Dermatology) Áö³­´Þ 6ÀÏ¿¡ °ÔÀçµÆ´Ù.

¹Ì±¹ÇǺΰúÇÐȸÁö´Â 2020³â ¿µÇâ·ÂÁö¼ö(impact factor) 11.527¿¡ ÇØ´çÇϸç, ÇǺΰúÇÐ ºÐ¾ßÀÇ ±¹Á¦ ÇмúÁö ÃÑ 89°³ Áß 1À§¿¡ µîÀçµÇ¾î ÀÖ´Ù.

2020³â ÇѾç´ëÇб³ ½ÅÀÓ±³¼öÁ¤Âø ¿¬±¸Áö¿ø»ç¾÷ÀÇ Áö¿øÀ» ¹Þ¾Æ ¼öÇàµÈ À̹ø ³í¹®ÀÇ Á¦¸ñÀº ‘´ë±â¿À¿° ³ëÃâÀÌ ¾ÆÅäÇÇÇǺο° ¹ß»ý¿¡ ¹ÌÄ¡´Â ¿µÇâ(Exposure to air pollution and incidence of atopic dermatitis in the general population: A national population-based retrospective cohort study)’À¸·Î 209,168¸íÀÇ ´ë»óÀÚ¸¦ Àå±â°£ ÃßÀû°üÂûÇÏ¿©, Ãʹ̼¼¸ÕÁö(PM2.5), ¹Ì¼¼¸ÕÁö(PM10), ÀÌ»êȭȲ(SO2), ÀÌ»êÈ­Áú¼Ò(NO2), ÀÏ»êȭź¼Ò(CO)ÀÇ Àå±â°£ ³ëÃâÀÌ °¢°¢ µ¶¸³ÀûÀ¸·Î ¾ÆÅäÇÇÇǺο°ÀÇ ¹ß»ýÀ§ÇèÀ» Áõ°¡½ÃÅ´À» º¸°íÇß´Ù.

ƯÈ÷ Á÷°æ 2.5μm ÀÌÇÏÀÎ Ãʹ̼¼¸ÕÁö¿Í Á÷°æ 10μm ÀÌÇÏÀÎ ¹Ì¼¼¸ÕÁöÀÇ °æ¿ì Àå±â°£ Æò±Õ ³óµµ°¡ 1 μg/m3 Áõ°¡ÇÔ¿¡ µû¶ó ¾ÆÅäÇÇÇǺο° ¹ß»ýÀ§ÇèÀº °¢°¢ 42.0%, 33.3%°¡ Áõ°¡ÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µ´Ù.

¼­Çö¹Î ±³¼ö´Â ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐÀ» Á¹¾÷ÇÏ°í ¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ ÇǺΰúÇб³½Ç¿¡¼­ ¼®»ç¸¦, ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ ÇǺΰúÇб³½Ç¿¡¼­ ¹Ú»çÇÐÀ§¸¦ ÃëµæÇßÀ¸¸ç, ÇöÀç ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ ÇǺΰúÇб³½Ç¿¡¼­ Á¶±³¼ö·Î ÀçÁ÷ ÁßÀÌ´Ù. ´ëÇÑÇǺΰúÇÐȸ Á¤È¸¿ø, ´ëÇÑÇǺΰúÇÐȸ °í½ÃÀ§¿ø, ´ëÇÑÇǺΰúÇÐȸ È«º¸À§¿ø, ´ëÇÑÀÇÁø±ÕÇÐȸ/´ëÇÑÇǺÎÁø±ÕÇÐȸ À繫°£»ç, ´ëÇÑÇǺη¹ÀÌÀúÇÐȸ Ãѹ«°£»ç, ´ëÇѹ̿ëÇǺοܰúÇÐȸ Á¤º¸°£»ç, ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ È«º¸À§¿øµî È°¹ßÇÑ È°µ¿À» ÇÏ°í ÀÖ´Ù.

°ü·Ã±â»ç°¡ ¾ø½À´Ï´Ù
´º½º½ºÅ©·¦Çϱâ
Á¶ÇöÁø (bktimes@naver.com) ±âÀÚ 
À̱âÀÚÀÇ ´Ù¸¥´º½ºº¸±â
µ¿Á¤¼½¼Ç ¸ñ·ÏÀ¸·Î
±èºØ³â ±³¼ö, ±¹Á¦¼Ò¾Æû¼Ò...
°æÈñ´ëº´¿ø È«½ÂÀç ±³¼ö °Ç...
°í·Á´ëÇб³ °­¹Î¼® ±³¼ö, ...
°ûÁ¤¸é ±³¼ö, °í´ëÀÇ°ú´ë '...
¹Ú½ÂÇÏ °í·Á´ëº´¿øÀå, ¼ººÏ...
´ÙÀ½±â»ç : °æÈñ´ëº´¿ø ±èÈ¿Á¾ ±³¼ö, ¼¼°èÀû ÀÇÇÐ ÇмúÁö ¡¯Lancet¡®¿¡ ³í¹® °ÔÀç (2021-07-16 09:43:00)
ÀÌÀü±â»ç : ºÐ´ç¼­¿ï´ëº´¿ø Ȳ¿ì¿¬ Àü¹®ÀÇ, '´ëÇѺñ´¢ºÎÀΰúÇÐȸ ÃÖ¿ì¼ö ±¸¿¬»ó' (2021-07-16 09:12:47)
º´¿ø°è, "°è...
º´¿ø°è, "°è¹¦³â...
Á¦¾à¡¤°Ç½Ä 12°³...
°Çº¸°ø´Ü, ¼Ò¼Ó±â°ü '¼­¿ï¿ä¾ç...
¼ºÀåÇÏ°íÇ ´ç½Å, "Áö±Ý ´ë¿õ,...
º¸·ÉÁ¦¾à, ¿Ã »ó¹Ý±â '¿µ¾÷Á÷ ...
°Çº¸°ø´Ü, ¿ÃÇØ '°³¹æÇü Á÷°ú ...
°Çº¸°ø´Ü, '¿Ã Á¦3Â÷ °³¹æÇü ...
³í¹®) Overcoming BRAF and CDK4/6 inhibitor ...  
ȸ»ç¼Ò°³ °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ ÀÌ¿ë¾à°ü À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ ¾Ë¸³´Ï´Ù º¸µµÀÚ·á ±â»çÁ¦º¸ Á¤±â±¸µ¶